Online citations, reference lists, and bibliographies.
← Back to Search

Full Factorial Design, Physicochemical Characterisation And Biological Assessment Of Cyclosporine A Loaded Cationic Nanoparticles.

K. Hermans, D. Van den Plas, Arnout Everaert, W. Weyenberg, A. Ludwig
Published 2012 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Cyclosporine A loaded poly(lactide-co-glycolide) nanoparticles coated with chitosan were prepared using the o/w emulsification solvent evaporation method. A 2(3) full factorial design was used to investigate the effect of 3 preparation parameters on the particle size, polydispersity index, zeta potential and drug release. In vitro experiments were performed in order to evaluate the cytotoxicity and anti-inflammatory activity of the developed nanoparticles. Particle sizes varied from 156 nm to 314 nm, and polydispersity index values of 0.07-0.56 were obtained depending on the different preparation parameters. All nanoparticles showed positive zeta potential values. Nanoparticles prepared with the highest concentration chitosan retained a positive zeta potential after dispersion in simulated lachrymal fluid, which supports the possibility of an electrostatic interaction between these particles and the negatively charged mucus layer at the eye. The in vitro release profile of cyclosporine A from the chitosan-coated nanoparticles was strongly dependent on the release medium used. None of the cationic nanoparticle formulations showed significant cytotoxicity compared to the negative control using human epithelial cells (HaCaT). Cyclosporine A encapsulated in the various nanoparticle formulations remained anti-inflammatory active as significant suppression of interleukine-2 secretion in concanavalin A stimulated Jurkat T cells was observed.
This paper references
10.1016/J.ADDR.2005.07.005
The use of mucoadhesive polymers in ocular drug delivery.
A. Ludwig (2005)
10.1023/A:1016015803611
Polyester Nanocapsules as New Topical Ocular Delivery Systems for Cyclosporin A
P. Calvo (2004)
[Quaternary ammonium cytotoxicity in a human conjunctival cell line].
C. Debbasch (1999)
10.2174/0929867033457160
Cyclophilin D as a drug target.
P. Waldmeier (2003)
10.1016/S0939-6411(03)00138-3
Cyclosporine A delivery to the eye: a pharmaceutical challenge.
F. Lallemand (2003)
10.1016/S1773-2247(07)50007-9
Evaluation of the physicochemical characteristics and activity of various kinds of ciprofloxacin HCl-loaded cationic nanoparticles
K. Dillen (2007)
10.1016/S0378-5173(01)00760-8
Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.
A. M. de Campos (2001)
10.1080/01932690802498666
Influence of Chitosan Layer on the Properties of Surface Modified Poly(lactide-co-glycolide) Nanoparticles
K. Yoncheva (2009)
10.1248/CPB.52.1273
Influence of the homogenisation procedure on the physicochemical properties of PLGA nanoparticles.
J. Vandervoort (2004)
10.1016/J.AJO.2003.10.036
Antiinflammatory therapy for dry eye.
S. Pflugfelder (2004)
10.1016/S0378-5173(97)00083-5
Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers
P. Calvo (1997)
10.1016/S0939-6411(97)00150-1
Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.
A. Zur Mühlen (1998)
10.1016/S0378-5173(99)00003-4
Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention.
O. Felt (1999)
10.1016/j.taap.2010.08.029
Uptake and cytotoxicity of chitosan nanoparticles in human liver cells.
Jing Wen Loh (2010)
10.1007/978-1-4615-0717-8_97
Relationship between in vitro toxicity of benzalkonium chloride (BAC) and preservative-induced dry eye.
M. de Saint Jean (2002)
10.3109/02652049109021873
Studies on the transport pathway of PBCA nanoparticles in ocular tissues.
A. Zimmer (1991)
10.1097/ICO.0b013e3181dc81b6
Influence of Alkyl Chain Length of Benzalkonium Chloride on Acute Corneal Epithelial Toxicity
M. Uematsu (2010)
Cyclosporin A blocks calcium-dependent pathways of gene activation.
C. Baldari (1991)
10.1016/J.JCONREL.2004.08.007
Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody.
A. Lukyanov (2004)
10.1016/J.EJPB.2004.03.035
The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles.
K. Dillen (2004)
10.1016/S0168-3659(99)00192-3
Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption.
S. Law (2000)
10.1016/J.SURVOPHTHAL.2009.08.001
Topical Ophthalmic Cyclosporine: Pharmacology and Clinical Uses
E. Donnenfeld (2009)
10.1016/S0928-0987(02)00057-X
Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen.
R. Pignatello (2002)
10.1111/j.2042-7158.1996.tb03911.x
Improved Ocular Bioavailability of Indomethacin by Novel Ocular Drug Carriers
P. Calvo (1996)
10.1097/01.ICO.0000133994.22392.47
Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca.
Bradley D Strong (2005)
10.1089/JOP.1986.2.67
Topical ocular drug delivery: recent developments and future challenges.
V. Lee (1986)
10.1016/j.jconrel.2011.01.010
Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies.
P. Aksungur (2011)
10.1016/J.IJPHARM.2006.01.041
Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
K. Dillen (2006)
10.1016/S0161-6420(93)31558-7
Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye.
J. K. Milani (1993)
10.3748/WJG.V11.I33.5136
In vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells.
Li-feng Qi (2005)
10.1211/0022357022476
The potential of chitosan in ocular drug delivery
M. Alonso (2003)
10.1211/0022357023835
Eudragit RL100 nanoparticle system for the ophthalmic delivery of cloricromene
C. Bucolo (2004)
10.1016/0169-409X(92)90007-D
(D) Routes of delivery: Case studies
D. Harris (1992)



This paper is referenced by
10.2174/2210303109666191202102517
Development of Polymeric Nanocarriers for Brain Targeted Delivery of Atorvastatin: A Quality-By-Design Approach
G. G. Martins (2020)
10.3109/10837450.2014.979942
Amphotericin B-loaded polymeric nanoparticles: formulation optimization by factorial design
T. C. M. M. Carraro (2016)
10.5681/bi.2013.016
Application of response surface methodology in development of sirolimus liposomes prepared by thin film hydration technique.
S. Ghanbarzadeh (2013)
10.1515/ejnm-2015-0034
Preparation and characterization of nanoparticles composed of methylated N-(4-N,N-dimethyl aminobenzyl) chitosan for oral delivery of cyclosporine A
Reza Mahjub (2016)
10.1016/j.ejps.2016.01.012
Polymeric nanoparticles for oral delivery of 5-fluorouracil: Formulation optimization, cytotoxicity assay and pre-clinical pharmacokinetics study.
Ana Cristina de Mattos (2016)
10.22159/IJAP.2018V10I2.24238
APPLICATION OF RESPONSE SURFACE METHODOLOGY IN OPTIMIZATION OF PACLITAXEL LIPOSOMES PREPARED BY THIN FILM HYDRATION TECHNIQUE
A. A. Tatode (2018)
10.3390/app10124189
Biofabrication of Chitosan-Based Nanomedicines and Its Potential Use for Translational Ophthalmic Applications
Riddhi Vichare (2020)
Sirolimus Nano Liposomes Optimization of sirolimus nano liposome prepared by modified ethanol injection method using response surface methodology
S. Ghanbarzadeh (2013)
10.1007/978-3-319-41421-8_14
Drug Delivery by Polymer Nanoparticles: The Challenge of Controlled Release and Evaluation
C. Charrueau (2016)
10.1111/vop.12173
Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study.
L. Barachetti (2015)
10.7555/JBR.32.20160170
Preparation, optimization, and characterization of chitosan-coated solid lipid nanoparticles for ocular drug delivery
F. Wang (2018)
10.2147/IJN.S90866
Investigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticles
S. Jahan (2015)
10.1016/j.ijpharm.2014.06.017
Development and characterization of mucoadhesive chitosan films for ophthalmic delivery of cyclosporine A.
K. Hermans (2014)
10.3390/pharmaceutics12030253
Assembling Surfactants-Mucoadhesive Polymer Nanomicelles (ASMP-Nano) for Ocular Delivery of Cyclosporine-A
E. Terreni (2020)
10.15171/bi.2016.26
Filgrastim (G-CSF) loaded liposomes: mathematical modeling and optimization of encapsulation efficiency and particle size
Farhad Kiafar (2016)
10.1007/s10973-019-08197-6
Temperature-dependent interactions in the chitosan/cyclosporine A system at liquid–air interface
M. Jurak (2019)
10.2147/IJN.S90849
Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity
M. Guada (2015)
10.1016/J.COLSURFA.2018.07.005
Polyelectrolyte-coated nanocapsules containing cyclosporine A protect neuronal-like cells against oxidative stress-induced cell damage
M. Piotrowski (2018)
10.1016/j.jconrel.2020.10.026
Drug-integrating amphiphilic nanomaterial assemblies: 1. Spatiotemporal control of cyclosporine delivery and activity using nanomicelles and nanofibrils.
D. Velluto (2020)
10.1016/j.jconrel.2016.01.056
Reformulating cyclosporine A (CsA): More than just a life cycle management strategy.
M. Guada (2016)
DESIGN AND DEVELOPMENT OF NICOTIANA TABACUM FILM USING FACTORIAL DESIGN
Anwar Siraj Daud (2016)
10.7705/biomedica.v37i1.2995
Síntesis de nanopartículas de ácido poli-láctico cargadas con antibióticos y su actividad antibacteriana contra Escherichia coli O157:H7 y Staphylococcus aureus resistente a meticilina
M. T. Herrera (2017)
10.1016/J.AJPS.2015.10.064
Auricularia auricular polysaccharide-low molecular weight chitosan polyelectrolyte complex nanoparticles: Preparation and characterization
W. Xiong (2016)
ESTUDO DE PRÉ-FORMULAÇÃO DE NANOPARTÍCULAS POLIMÉRICAS PARA VEICULAÇÃO DA L-ASPARAGINASE
Camila de Oliveira Melo (2016)
10.1007/978-3-319-41421-8_13
Associating Drugs with Polymer Nanoparticles: A Challenge
C. Zandanel (2016)
10.1208/s12249-016-0669-x
Development of Timolol-Loaded Galactosylated Chitosan Nanoparticles and Evaluation of Their Potential for Ocular Drug Delivery
Ruobing Zhao (2016)
10.1016/j.ejpb.2017.03.006
Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts
F. Lallemand (2017)
10.1016/j.ijpharm.2018.05.015
Sorbitan ester nanoparticles (SENS) as a novel topical ocular drug delivery system: Design, optimization, and in vitro/ex vivo evaluation
J. Álvarez-Trabado (2018)
10.1089/JOP.2016.0013
Formulation and In Vitro Evaluation of Cyclosporine-A Inserts Prepared Using Hydroxypropyl Methylcellulose for Treating Dry Eye Disease.
H. F. Al-SaediZahraa (2016)
10.1016/j.ejps.2018.03.014
Co‐nanoencapsulation of antimalarial drugs increases their in vitro efficacy against Plasmodium falciparum and decreases their toxicity to Caenorhabditis elegans
Kelle Velasques (2018)
Semantic Scholar Logo Some data provided by SemanticScholar